JEAP 2026 Opens applications for regenerative medicine companies

JEAP - Japan Entry Acceleration Program 2026, supported by the Forum for Innovative Regenerative Medicine (FIRM), provides the network, insights, and resources needed to accelerate business growth in Japan, one of the world’s most advanced healthcare and life sciences markets.
Designed for innovative global companies, the programme offers a unique opportunity to explore the Japanese market and build meaningful connections with key stakeholders across the healthcare ecosystem. Through tailored mentorship, business matching support, site visits, and a final Demo Day, selected companies will gain access to leading KOLs, CDMOs, pharmaceutical companies, and investors while developing practical insights into market entry, partnership development, and regulatory considerations for business expansion in Japan.
For companies looking to expand their presence in Asia and engage with potential partners in Japan, JEAP 2026 offers an ideal platform to establish a foothold in Japan and accelerate participants growth across the Asia-Pacific region.
Application deadline: 16 October 2026. 
Source: JETRO
https://www.jetro.go.jp/en/invest/newsroom/2026/596d2181915cac22.html 

Published: October 2026